Clinical Trial Update: Adaptive Radiotherapy for Safe Hypofractionation [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update describes adaptive radiotherapy to enable safe hypofractionation across several cancers. The study is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Endometrial Cancer
• Prostate Cancer
• Rectal Cancer

Snippet

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) | Conditions: Cancer, Endometrial Cancer | Phase 2 | Status: NOT_YET_RECRUITING